Literature DB >> 15886326

GPVI and alpha2beta1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow.

Kendra L Sarratt1, Hong Chen, Mary M Zutter, Samuel A Santoro, Daniel A Hammer, Mark L Kahn.   

Abstract

The roles of the 2 major platelet-collagen receptors, glycoprotein VI (GPVI) and integrin alpha2beta1, have been intensely investigated using a variety of methods over the past decade. In the present study, we have used pharmacologic and genetic approaches to study human and mouse platelet adhesion to collagen under flow conditions. Our studies demonstrate that both GPVI and integrin alpha2beta1 play significant roles for platelet adhesion to collagen under flow and that the loss of both receptors completely ablates this response. Intracellular signaling mediated by the cytoplasmic adaptor Src homology 2 domain-containing leukocyte protein of 76 kDa (SLP-76) but not by the transmembrane adaptor linker for activation of T cells (LAT) is critical for platelet adhesion to collagen under flow. In addition, reduced GPVI receptor density results in severe defects in platelet adhesion to collagen under flow. Defective adhesion to collagen under flow is associated with prolonged tail-bleeding times in mice lacking one or both collagen receptors. These studies establish platelet-collagen responses under physiologic flow as the consequence of a close partnership between 2 structurally distinct receptors and suggest that both receptors play significant hemostatic roles in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15886326      PMCID: PMC1895202          DOI: 10.1182/blood-2004-11-4434

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  48 in total

1.  Roles of SLP-76, phosphoinositide 3-kinase, and gelsolin in the platelet shape changes initiated by the collagen receptor GPVI/FcR gamma-chain complex.

Authors:  H Falet; K L Barkalow; V I Pivniouk; M J Barnes; R S Geha; J H Hartwig
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

2.  Expression and function of the mouse collagen receptor glycoprotein VI is strictly dependent on its association with the FcRgamma chain.

Authors:  B Nieswandt; W Bergmeier; V Schulte; K Rackebrandt; J E Gessner; H Zirngibl
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

3.  The platelet receptor GPVI mediates both adhesion and signaling responses to collagen in a receptor density-dependent fashion.

Authors:  Hong Chen; Darren Locke; Ying Liu; Changdong Liu; Mark L Kahn
Journal:  J Biol Chem       Date:  2001-11-26       Impact factor: 5.157

4.  Integrin alpha 2-deficient mice develop normally, are fertile, but display partially defective platelet interaction with collagen.

Authors:  Olaf Holtkötter; Bernhard Nieswandt; Neil Smyth; Werner Müller; Martin Hafner; Valerie Schulte; Thomas Krieg; Beate Eckes
Journal:  J Biol Chem       Date:  2002-01-11       Impact factor: 5.157

5.  LAT is required for tyrosine phosphorylation of phospholipase cgamma2 and platelet activation by the collagen receptor GPVI.

Authors:  J M Pasquet; B Gross; L Quek; N Asazuma; W Zhang; C L Sommers; E Schweighoffer; V Tybulewicz; B Judd; J R Lee; G Koretzky; P E Love; L E Samelson; S P Watson
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

Review 6.  The role of ITAM- and ITIM-coupled receptors in platelet activation by collagen.

Authors:  S P Watson; N Asazuma; B Atkinson; O Berlanga; D Best; R Bobe; G Jarvis; S Marshall; D Snell; M Stafford; D Tulasne; J Wilde; P Wonerow; J Frampton
Journal:  Thromb Haemost       Date:  2001-07       Impact factor: 5.249

7.  Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy.

Authors:  Sabine Grüner; Miroslava Prostredna; Barsom Aktas; Alexandra Moers; Valerie Schulte; Thomas Krieg; Stefan Offermanns; Beate Eckes; Bernhard Nieswandt
Journal:  Circulation       Date:  2004-10-25       Impact factor: 29.690

8.  Sialyl Lewis(x)-mediated, PSGL-1-independent rolling adhesion on P-selectin.

Authors:  S D Rodgers; R T Camphausen; D A Hammer
Journal:  Biophys J       Date:  2000-08       Impact factor: 4.033

9.  Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen.

Authors:  B Nieswandt; C Brakebusch; W Bergmeier; V Schulte; D Bouvard; R Mokhtari-Nejad; T Lindhout; J W Heemskerk; H Zirngibl; R Fässler
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

10.  Differential requirement for LAT and SLP-76 in GPVI versus T cell receptor signaling.

Authors:  Barbi A Judd; Peggy S Myung; Achim Obergfell; Erin E Myers; Alec M Cheng; Stephen P Watson; Warren S Pear; David Allman; Sanford J Shattil; Gary A Koretzky
Journal:  J Exp Med       Date:  2002-03-18       Impact factor: 14.307

View more
  42 in total

1.  Loss of GPVI and GPIbα contributes to trauma-induced platelet dysfunction in severely injured patients.

Authors:  Paul Vulliamy; Samantha J Montague; Scarlett Gillespie; Melissa V Chan; Lucy A Coupland; Robert K Andrews; Timothy D Warner; Elizabeth E Gardiner; Karim Brohi; Paul C Armstrong
Journal:  Blood Adv       Date:  2020-06-23

2.  Occlusive thrombi arise in mammals but not birds in response to arterial injury: evolutionary insight into human cardiovascular disease.

Authors:  Alec A Schmaier; Timothy J Stalker; Jeffrey J Runge; Dooyoung Lee; Chandrasekaran Nagaswami; Patricia Mericko; Mei Chen; Simon Cliché; Claude Gariépy; Lawrence F Brass; Daniel A Hammer; John W Weisel; Karen Rosenthal; Mark L Kahn
Journal:  Blood       Date:  2011-08-03       Impact factor: 22.113

3.  Synergism between platelet collagen receptors defined using receptor-specific collagen-mimetic peptide substrata in flowing blood.

Authors:  Nicholas Pugh; Anna M C Simpson; Peter A Smethurst; Philip G de Groot; Nicolas Raynal; Richard W Farndale
Journal:  Blood       Date:  2010-03-29       Impact factor: 22.113

4.  Thrombogenic collagen-mimetic peptides: Self-assembly of triple helix-based fibrils driven by hydrophobic interactions.

Authors:  Mabel A Cejas; William A Kinney; Cailin Chen; Jeremy G Vinter; Harold R Almond; Karin M Balss; Cynthia A Maryanoff; Ute Schmidt; Michael Breslav; Andrew Mahan; Eilyn Lacy; Bruce E Maryanoff
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-16       Impact factor: 11.205

5.  The Modifier of hemostasis (Mh) locus on chromosome 4 controls in vivo hemostasis of Gp6-/- mice.

Authors:  Yann Cheli; Deborah Jensen; Patrizia Marchese; David Habart; Tim Wiltshire; Michael Cooke; José A Fernandez; Jerry Ware; Zaverio M Ruggeri; Thomas J Kunicki
Journal:  Blood       Date:  2007-11-08       Impact factor: 22.113

6.  Standardizing a simpler, more sensitive and accurate tail bleeding assay in mice.

Authors:  Yang Liu; Nicole L Jennings; Anthony M Dart; Xiao-Jun Du
Journal:  World J Exp Med       Date:  2012-04-20

7.  New assay to detect low-affinity interactions and characterization of leukocyte receptors for collagen including leukocyte-associated Ig-like receptor-1 (LAIR-1).

Authors:  Lei Jiang; A Neil Barclay
Journal:  Eur J Immunol       Date:  2009-04       Impact factor: 5.532

Review 8.  Platelet receptors and signaling in the dynamics of thrombus formation.

Authors:  José Rivera; María Luisa Lozano; Leyre Navarro-Núñez; Vicente Vicente
Journal:  Haematologica       Date:  2009-03-13       Impact factor: 9.941

9.  Molecular priming of Lyn by GPVI enables an immune receptor to adopt a hemostatic role.

Authors:  Alec A Schmaier; Zhiying Zou; Arunas Kazlauskas; Lori Emert-Sedlak; Karen P Fong; Keith B Neeves; Sean F Maloney; Scott L Diamond; Satya P Kunapuli; Jerry Ware; Lawrence F Brass; Thomas E Smithgall; Kalle Saksela; Mark L Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-25       Impact factor: 11.205

10.  Differential roles for the adapters Gads and LAT in platelet activation by GPVI and CLEC-2.

Authors:  C E Hughes; J M Auger; J McGlade; J A Eble; A C Pearce; S P Watson
Journal:  J Thromb Haemost       Date:  2008-09-27       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.